Shopping Cart
Remove All
Your shopping cart is currently empty
VU0364572 TFA is a selective allosteric agonist of the M1 muscarinic receptor with an EC50 of 0.11 μM. It demonstrates neuroprotective potential by preventing memory impairment and reducing neuropathology associated with Alzheimer's disease. Additionally, VU0364572 TFA is orally active and permeates the central nervous system.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks | 4-6 weeks |
| Description | VU0364572 TFA is a selective allosteric agonist of the M1 muscarinic receptor with an EC50 of 0.11 μM. It demonstrates neuroprotective potential by preventing memory impairment and reducing neuropathology associated with Alzheimer's disease. Additionally, VU0364572 TFA is orally active and permeates the central nervous system. |
| In vitro | VU0364572 (30 μM; 25 min) enhances the phosphorylation of KCNQ2, NR1, and MARCKS in striatal/NAc slices [2]. |
| In vivo | VU0364572 (10 mg/kg/day; oral; 4 months) TFA demonstrates neuroprotective effects in 5XFAD transgenic Alzheimer's mice. The half-life of VU0364572 is 45 minutes [1]. |
| Molecular Weight | 373.49 |
| Formula | C21H31N3O3 |
| Cas No. | 1240514-87-7 |
| Smiles | N(C(=O)C1=C(C)C=CC=C1)[C@H]2CN(C3CCN(C(OCC)=O)CC3)CCC2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.